Corticosteroid derivatives - IVAX

Drug Profile

Corticosteroid derivatives - IVAX

Alternative Names: Soft steroids - IVAX

Latest Information Update: 07 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IVAX Corporation
  • Developer IVAX Drug Research Institute
  • Class
  • Mechanism of Action Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Allergic conjunctivitis; Allergic rhinitis; Emphysema; Inflammation

Most Recent Events

  • 27 Jan 2006 IVAX Corporation has been acquired by Teva Pharmaceutical Industries
  • 14 Jun 2001 Preclinical development for Emphysema in Hungary (Inhalation)
  • 31 Dec 1999 Preclinical development for Allergic conjunctivitis in Hungary (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top